Metraipolis › archive › dc_5ece5e71d305

Enhancement of gemcitabine toxicity and specificity through PI3K/Akt/Nrf2 pathway inhibition in pancreatic cancer — Europe PMC PMID:41777246

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41777246
DOI
10.3389/fphar.2026.1724989
License (as archived)
solo-consultazione
Archived
2026-11-05T17:53:33.247Z
SHA-256 of the archived text
6324a2854117833759c4c2be73e0a1f275858183905cd35c1385b5800717d59b
Stable URL of this page
https://metraipolis.com/documento/dc_5ece5e71d305

How to cite

Enhancement of gemcitabine toxicity and specificity through PI3K/Akt/Nrf2 pathway inhibition in pancreatic cancer — Europe PMC PMID:41777246 — Europe PMC (en), https://europepmc.org/article/MED/41777246 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ece5e71d305 (Metraipolis archive dc_5ece5e71d305, sha256 6324a2854117833759c4c2be73e0a1f275858183905cd35c1385b5800717d59b)
BibTeX
@misc{dc5ece5e71d305,
  title = {Enhancement of gemcitabine toxicity and specificity through PI3K/Akt/Nrf2 pathway inhibition in pancreatic cancer — Europe PMC PMID:41777246},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41777246},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ece5e71d305; sha256 6324a2854117833759c4c2be73e0a1f275858183905cd35c1385b5800717d59b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41777246. Agents can read the archived copy with the MCP tool read_document.